John Anthony Loadsman

John Anthony Loadsman

Auto-generated profile, based on publicly available information

John Anthony Loadsman

Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2011 in Anaesthesia and Intensive Care
Verified
Journal Article
Open access
PDF file
PMP. E. Macintyre
P. E. Macintyre
JLJ. A. Loadsman
J. A. Loadsman
DSD. A. Scott
D. A. Scott
Despite the increasing use of a variety of different analgesic strategies, opioids continue as the mainstay for management of moderate to severe acute pain. However, concerns remain about their potential adverse effects on ventilation. The most commonly used term, respiratory depression, only describes part of that risk. Opioid-induced ventilatory impairment (OIVI) is a more complete term encompassing opioid-induced central respiratory depression (decreased respiratory drive), decreased level of consciousness (sedation) and upper airway obstruction, all of which, alone or in combination, may result in decreased alveolar ventilation and increased arterial carbon dioxide levels. Concerns about OIVI are warranted, as deaths related to opioid administration in the acute pain setting continue to be reported. Risks are often said to be higher in patients with obstructive sleep apnoea. However, the tendency to use the term ‘obstructive sleep apnoea’ to encompass the much broader spectrum of sleep- and obesity-related hypoventilation syndromes and the related misuse of terminology in papers relating to obstructive sleep apnoea and sleep-disordered breathing remain significant problems in discussions of opioid-related effects. Opioids given for management of acute pain must be titrated to effect for each patient. However, strategies aiming for better pain scores alone, without highlighting the need for appropriate monitoring of OIVI, can and will lead to an increase in adverse events. Therefore, all patients must be monitored appropriately for OIVI (at the very least using sedation scores as a ‘6th vital sign’) so that it can be detected at an early stage and appropriate interventions triggered.

1 February 2001 in British Journal of Anaesthesia
Verified
Journal Article
Open access
PDF file
JLJ. A. Loadsman
J. A. Loadsman
DHD. R. Hillman
D. R. Hillman
Br J Anaesth 2001; 86: 254–66

1 December 2004 in Sleep Medicine Reviews
Verified
Journal Article
Closed access
DHDavid R. Hillman
David R. Hillman
JLJohn A. Loadsman
John A. Loadsman
PPPeter R. Platt
Peter R. Platt
PEPeter R. Eastwood
Peter R. Eastwood

18 December 2016 in Anaesthesia
Verified
Journal Article
Closed access
PDF file
JCJ. B. Carlisle
J. B. Carlisle
JLJ. A. Loadsman
J. A. Loadsman

14 July 2023 in British Journal of Anaesthesia
Verified
Journal Article
Closed access
HBHannah E. Braithwaite
Hannah E. Braithwaite
TPThomas Payne
Thomas Payne
NDNicholas Duce
Nicholas Duce
JLJessica Lim
Jessica Lim
TMTim McCulloch
Tim McCulloch
RSRobert D. Sanders
Robert D. Sanders

1 September 2000 in British Journal of Anaesthesia
Verified
Journal Article
Open access
PDF file
JLJ. A. Loadsman
J. A. Loadsman
IWI. Wilcox
I. Wilcox
Obstructive sleep apnoea (OSA) is thought to be worse during rapid eye movement (REM) sleep. REM rebound in the late postoperative period can follow the REM suppression shown to occur after some types of surgery. This is thought to worsen nocturnal episodic hypoxaemia, leading to greater cardio‐respiratory risk. We set out to determine if OSA was a REM‐predominant phenomenon. We reviewed the sleep clinic records of 64 consecutive patients with a diagnosis of OSA on full overnight polysomnography and sufficient data to determine the presence of a sleep stage predominance. OSA was diagnosed if the number of apnoeas/hypopnoeas per hour of sleep, the respiratory disturbance index (RDI), was greater than 10. The variables recorded for the purposes of this study were the RDI and the minimum blood oxygen saturation using pulse oximetry (Sp o2min) for both REM and non‐rapid eye movement (NREM) sleep. All values are presented as mean (sd). The Wilcoxon signed rank test was used for statistical analysis. The means for NREM and REM RDI were, respectively, 36 (26) and 38 (27) per hour (P=0.96). In 32 of the 64 patients (50%) the RDI in NREM was greater than in REM. Thirty‐one (48%) had a larger number during REM. One patient had identical RDIs for both REM and NREM. Sixty‐two patients had satisfactory pulse oximetry recordings for both NREM and REM, and the mean Sp o2min values were, respectively, 84 (7) and 82 (13)% (P=0.15). Twenty‐nine patients (47%) had a lower Sp o2min in REM (seven by more than 10% and two by more than 40%), while 24 (39%) were lower in NREM (two by more than 10%). Nine patients (14%) had identical values in REM and NREM. In contrast to suggestions that OSA is a REM‐predominant phenomenon, this study suggests that respiratory disturbance is not greatly affected by sleep stage, in most patients. While a small number clearly desaturate much more during REM, the majority do not. Thus, postoperative REM rebound may worsen OSA in some patients, but in many it may do otherwise. The implications of postoperative sleep disturbance are therefore likely to be more complex than previously suggested. Br J Anaesth 2000; 85: 354–8